1.1 > 50% reduction in depressive symptoms |
1 |
67 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.16 [0.88, 1.52] |
1.2 Mean depression scores |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
1.2.1 HAMD scores |
1 |
67 |
Mean Difference (IV, Fixed, 95% CI) |
0.65 [‐2.15, 3.45] |
1.3 Withdrawals (any reason) |
1 |
67 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.15 [0.01, 2.74] |
1.4 Adverse effects |
1 |
|
Risk Ratio (M‐H, Fixed, 99% CI) |
Subtotals only |
1.4.1 Blurred vision |
1 |
67 |
Risk Ratio (M‐H, Fixed, 99% CI) |
0.34 [0.09, 1.32] |
1.4.2 Dizziness |
1 |
67 |
Risk Ratio (M‐H, Fixed, 99% CI) |
0.21 [0.03, 1.37] |
1.4.3 Dry mouth |
1 |
67 |
Risk Ratio (M‐H, Fixed, 99% CI) |
0.26 [0.06, 1.20] |
1.4.4 Sleep disorders |
1 |
67 |
Risk Ratio (M‐H, Fixed, 99% CI) |
0.32 [0.08, 1.20] |
1.4.5 Urinary retention |
1 |
67 |
Risk Ratio (M‐H, Fixed, 99% CI) |
0.34 [0.01, 21.99] |